{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:45:05Z","timestamp":1792453505240,"version":"4.5.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Inflammatory Bowel Disease (IBD), encompassing Crohn\u2019s disease and ulcerative colitis, is an umbrella term used to describe a group of autoimmune conditions characterized by chronic, relapsing inflammation of the gastrointestinal tract. The tumour necrosis factor superfamily member 14 (TNFSF14), also known as LIGHT, is a pleiotropic cytokine with diverse roles in immune regulation. Here, we review the multifaceted involvement of LIGHT in intestinal inflammation, particularly its dual capacity to both promote immune activation and facilitate inflammation resolution in the context of IBD. We explore the molecular mechanisms of LIGHT signalling through its receptors, Herpes Virus Entry Mediator (HVEM) and Lymphotoxin-\u03b2 Receptor (LT\u03b2R), and how these distinct interactions dictate its pro-inflammatory or regulatory functions. Finally, we review the therapeutic potential of targeting this pathway, highlighting the results of recent clinical trials and exploring future strategies aimed at restoring immune homeostasis in patients with IBD.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1657071","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:28:54Z","timestamp":1757914134000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["TNFSF14 (LIGHT) in intestinal inflammation: balancing immune activation and resolution in IBD"],"prefix":"10.3389","volume":"16","author":[{"given":"Rabia S.","family":"Mousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani S.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Berre","year":"2023","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02586-2","article-title":"Crohn\u2019s disease","volume":"403","author":"Dolinger","year":"2024","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fgstr.2024.1452430","article-title":"Innate immune cells in the pathogenesis of inflammatory bowel disease - from microbial metabolites to immune modulation","volume":"3","author":"Mousa","year":"2024","journal-title":"Front Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00762.x","article-title":"Immunoregulation by tumor necrosis factor superfamily member LIGHT","volume":"229","author":"Wang","year":"2009","journal-title":"Immunol Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.9.5122","article-title":"Genomic characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis1\u20082","volume":"167","author":"Granger","year":"2001","journal-title":"J Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1600-065X.2008.00629.x","article-title":"Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways","volume":"223","author":"Ware","year":"2008","journal-title":"Immunol Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.01.011","article-title":"Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer","volume":"81","author":"Lin","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e20220236","DOI":"10.1084\/jem.20220236","article-title":"Realigning the LIGHT signaling network to control dysregulated inflammation","volume":"219","author":"Ware","year":"2022","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00617","article-title":"BTLA\/HVEM signaling: milestones in research and role in chronic hepatitis B virus infection","volume":"10","author":"Yu","year":"2019","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071160","article-title":"A crucial role for HVEM and BTLA in preventing intestinal inflammation","volume":"205","author":"Steinberg","year":"2008","journal-title":"J Exp Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1053\/j.gastro.2014.02.010","article-title":"The tumor necrosis factor family member TNFSF14 (LIGHT) is required for resolution of intestinal inflammation in mice","volume":"146","author":"Krause","year":"2014","journal-title":"Gastroenterology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901582","article-title":"Promoting immune responses by LIGHT in the face of abundant regulatory T cell inhibition","volume":"184","author":"Wang","year":"2010","journal-title":"J Immunol Baltim Md 1950"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.12.018","article-title":"The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF Superfamily member 14)","volume":"104","author":"Herro","year":"2016","journal-title":"Pharmacol Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2018.08.067","article-title":"Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease","volume":"175","author":"Kinchen","year":"2018","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.12.8173","article-title":"The critical role of LIGHT in promoting intestinal inflammation and crohn\u2019s disease1","volume":"174","author":"Wang","year":"2005","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1385\/IR:30:2:201","article-title":"The role of LIGHT in T cell-mediated immunity","volume":"30","author":"Wang","year":"2004","journal-title":"Immunol Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.11.6330","article-title":"Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction","volume":"167","author":"Shaikh","year":"2001","journal-title":"J Immunol Baltim Md 1950"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nature11242","article-title":"HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria","volume":"488","author":"Shui","year":"2012","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.mucimm.2024.02.004","article-title":"Intraepithelial lymphocytes promote intestinal regeneration through CD160\/HVEM signaling","volume":"17","author":"Huang","year":"2024","journal-title":"Mucosal Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1388496","article-title":"LT\u03b2R-RelB signaling in intestinal epithelial cells protects from chemotherapy-induced mucosal damage","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chom.2011.06.002","article-title":"Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge","volume":"10","author":"Tumanov","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.02.011","article-title":"Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection","volume":"32","author":"Wang","year":"2010","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2012.02.118","article-title":"Lymphotoxin-beta receptor activation on macrophages ameliorates acute DSS-induced intestinal inflammation in a TRIM30\u03b1-dependent manner","volume":"51","author":"Wimmer","year":"2012","journal-title":"Mol Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2024828118","DOI":"10.1073\/pnas.2024828118","article-title":"An epithelial Nfkb2 pathway exacerbates intestinal inflammation by supplementing latent RelA dimers to the canonical NF-\u03baB module","volume":"118","author":"Chawla","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s12276-021-00574-2","article-title":"Splenectomy improves liver fibrosis via tumor necrosis factor superfamily 14 (LIGHT) through the JNK\/TGF-\u03b21 signaling pathway","volume":"53","author":"Liang shan","year":"2021","journal-title":"Exp Mol Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12967-023-04381-3","article-title":"TNFSF14\/LIGHT promotes cardiac fibrosis and atrial fibrillation vulnerability via PI3K\u03b3\/SGK1 pathway-dependent M2 macrophage polarisation","volume":"21","author":"Wu","year":"2023","journal-title":"J Transl Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2005.03.009","article-title":"Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT\/HVEM signaling","volume":"52","author":"Giles","year":"2005","journal-title":"Pharmacol Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.02.052","article-title":"LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms","volume":"132","author":"Cohavy","year":"2007","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03131.x","article-title":"Neutralization of LIGHT ameliorates acute dextran sodium sulphate-induced intestinal inflammation","volume":"128","author":"Schwarz","year":"2009","journal-title":"Immunology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e18495","DOI":"10.1371\/journal.pone.0018495","article-title":"HVEM signalling promotes colitis","volume":"6","author":"Cardinale","year":"2011","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-021-00378-7","article-title":"Metabolic activation and colitis pathogenesis is prevented by lymphotoxin \u03b2 receptor expression in neutrophils","volume":"14","author":"Jaeger","year":"2021","journal-title":"Mucosal Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9238970","article-title":"Gene expression profiling of mediators associated with the inflammatory pathways in the intestinal tissue from patients with ulcerative colitis","volume":"2020","author":"Camarillo","year":"2020","journal-title":"Mediators Inflamm"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41467-021-22164-6","article-title":"Single-cell analyses of Crohn\u2019s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions","volume":"12","author":"Camarillo","year":"2021","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.727412","article-title":"Patients with microscopic colitis have altered levels of inhibitory and stimulatory biomarkers in colon biopsies and sera compared to non-inflamed controls","volume":"8","author":"\u015alebioda","year":"2021","journal-title":"Front Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200652","article-title":"Elevated levels of the cytokine LIGHT in pediatric crohn\u2019s disease","volume":"210","author":"An","year":"2023","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02585","article-title":"The tumor necrosis factor superfamily members TNFSF14 (LIGHT), lymphotoxin \u03b2 and lymphotoxin \u03b2 Receptor interact to regulate intestinal inflammation","volume":"9","author":"Jungbeck","year":"2018","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1556\/EuJMI.1.2011.1.9","article-title":"CD161 defines effector T cells that express light and respond to TL1A-DR3 signaling","volume":"1","author":"Cohavy","year":"2011","journal-title":"Eur J Microbiol Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/325129","article-title":"Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease","volume":"2014","author":"\u015alebioda","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13827","article-title":"The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT","volume":"108","author":"Riffelmacher","year":"2001","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2014.78","article-title":"Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells","volume":"8","author":"Macho-Fernandez","year":"2015","journal-title":"Mucosal Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.956694","article-title":"BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM","volume":"13","author":"Battin","year":"2022","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.10.008","article-title":"Immunomodulatory functions of BTLA and HVEM govern induction of extrathymic regulatory T cells and tolerance by dendritic cells","volume":"45","author":"Jones","year":"2016","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4161\/gmic.23443","article-title":"HVEM: An unusual TNF receptor family member important for mucosal innate immune responses to microbes","volume":"4","author":"Shui","year":"2013","journal-title":"Gut Microbes"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e20211112","DOI":"10.1084\/jem.20211112","article-title":"HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA\/CD160","volume":"218","author":"Liu","year":"2021","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.chom.2018.07.008","article-title":"LIGHT-HVEM signaling in innate lymphoid cell subsets protects against enteric bacterial infection","volume":"24","author":"Seo","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0241-1","article-title":"HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT","volume":"16","author":"Rodriguez-Barbosa","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020215","article-title":"Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis","volume":"195","author":"Scheu","year":"2002","journal-title":"J Exp Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016279","article-title":"Tumor necrosis factor superfamily in innate immunity and inflammation","volume":"7","author":"\u0160ed\u00fd","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01064.x","article-title":"The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation","volume":"244","author":"Steinberg","year":"2011","journal-title":"Immunol Rev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-009-0157-4","article-title":"Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners","volume":"31","author":"Steinberg","year":"2009","journal-title":"Semin Immunopathol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.10.6649","article-title":"Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells","volume":"180","author":"Tao","year":"2008","journal-title":"J Immunol Baltim Md 1950"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.987568","article-title":"Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers","volume":"13","author":"Tao","year":"2022","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"eabm6931","DOI":"10.1126\/sciimmunol.abm6931","article-title":"Epithelial HVEM maintains intraepithelial T cell survival and contributes to host protection","volume":"7","author":"Wang","year":"2022","journal-title":"Sci Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2017.47","article-title":"Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity","volume":"10","author":"Silberger","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.712632","article-title":"Redefining the role of lymphotoxin beta receptor in the maintenance of lymphoid organs and immune cell homeostasis in adulthood","volume":"12","author":"Silberger","year":"2021","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.29.2025","article-title":"Lymphtoxin beta receptor-Ig protects from T-cell-mediated liver injury in mice through blocking LIGHT\/HVEM signaling","volume":"29","author":"Shou","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1038\/ctg.2015.63","article-title":"Loss of response to anti-TNFs: definition, epidemiology, and management","volume":"7","author":"Roda","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e153173","DOI":"10.1172\/JCI153173","article-title":"Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome","volume":"132","author":"Roda","year":"2022","journal-title":"J Clin Invest"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/jimmun\/vkaf002","article-title":"Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis","volume":"214","author":"Perlin","year":"2025","journal-title":"J Immunol Baltim Md 1950"},{"key":"B62","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal cancer in inflammatory bowel disease: mechanisms and management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-023-01845-4","article-title":"Beyond the anti-PD-1\/PD-L1 era: promising role of the BTLA\/HVEM axis as a future target for cancer immunotherapy","volume":"22","author":"Shah","year":"2023","journal-title":"Mol Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.682007","article-title":"BTLA-HVEM couple in health and diseases: insights for immunotherapy in lung cancer","volume":"11","author":"Demerl\u00e9","year":"2021","journal-title":"Front Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116231","article-title":"The BTLA-HVEM complex \u2013 The future of cancer immunotherapy","volume":"268","author":"Wojciechowicz","year":"2024","journal-title":"Eur J Med Chem"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6439975","article-title":"Development and validation of a TNF family-based signature for predicting prognosis, tumor immune characteristics, and immunotherapy response in colorectal cancer patients","volume":"2021","author":"Wojciechowicz","year":"2021","journal-title":"J Immunol Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbad033","article-title":"Precision medicine in inflammatory bowel disease","volume":"6","author":"Zeng","year":"2023","journal-title":"Precis Clin Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpcb.4c02255","article-title":"Multilayered computational framework for designing peptide inhibitors of HVEM-LIGHT interaction","volume":"128","author":"Ciura","year":"2024","journal-title":"J Phys Chem B"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2010.06.002","article-title":"NF-\u03baB inducing kinase: A key regulator in the immune system and in cancer","volume":"21","author":"Thu","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-70630-6_13","article-title":"The LT beta R signaling pathway","volume":"597","author":"Ps","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.002649","article-title":"Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity","volume":"293","author":"Ps","year":"2018","journal-title":"J Biol Chem"},{"key":"B72","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/JIR.S40092","article-title":"The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium","volume":"6","author":"Kersting","year":"2013","journal-title":"J Inflammation Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020281","article-title":"Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor\u2013induced crohn\u2019s-like inflammatory bowel disease","volume":"196","author":"Kersting","year":"2002","journal-title":"J Exp Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2025.2464175","article-title":"NF-\u03baB-inducing kinase (NIK): an emerging therapeutic target in human disease","volume":"29","author":"Poole","year":"2025","journal-title":"Expert Opin Ther Targets"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.4c00044","article-title":"Pyrrolidinone derivatives as NIK inhibitors for treating inflammatory and autoimmune diseases","volume":"15","author":"Sabnis","year":"2024","journal-title":"ACS Med Chem Lett"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-024-01053-9","article-title":"Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer","volume":"23","author":"Croft","year":"2024","journal-title":"Nat Rev Drug Discov"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1657071\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:28:55Z","timestamp":1757914135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1657071\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":76,"alternative-id":["10.3389\/fimmu.2025.1657071"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1657071","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"article-number":"1657071"}}